Angiogenesis is an independent prognostic factor in malignant mesothelioma
Edwards, J. G., Cox, G., Andi, A., Jones, J. L., Walker, R. A., Waller, D. A., & O'Byrne, Kenneth J. (2001) Angiogenesis is an independent prognostic factor in malignant mesothelioma. British Journal of Cancer : BJC, 85(6), pp. 863-868.
Angiogenesis is essential for tumour growth beyond 1 to 2 mm in diameter. The clinical relevance of angiogenesis, as assessed by microvessel density (MVD), is unclear in malignant mesothelioma (MM). Immunohistochemistry was performed on 104 archival, paraffin-embedded, surgically resected MM samples with an anti-CD34 monoclonal antibody, using the Streptavidin-biotin complex immunoperoxidase technique. 93 cases were suitable for microvessel quantification. MVD was obtained from 3 intratumoural hotspots, using a Chalkley eyepiece graticule at × 250 power. MVD was correlated with survival by Kaplan-Meier and log-rank analysis. A stepwise, multivariate Cox model was used to compare MVD with known prognostic factors and the EORTC and CALGB prognostic scoring systems. Overall median survival from the date of diagnosis was 5.0 months. Increasing MVD was a poor prognostic factor in univariate analysis (P = 0.02). Independent indicators of poor prognosis in multivariate analysis were non-epithelial cell type (P = 0.002), performance status > 0 (P = 0.003) and increasing MVD (P = 0.01). In multivariate Cox analysis, MVD contributed independently to the EORTC (P = 0.006), but not to the CALGB (P = 0.1), prognostic groups. Angiogenesis, as assessed by MVD, is a poor prognostic factor in MM, independent of other clinicopathological variables and the EORTC prognostic scoring system. Further work is required to assess the prognostic importance of angiogenic regulatory factors in this disease. © 2001 Cancer Research Campaign.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Journal Article|
|Keywords:||Angiogenesis, Malignant mesothelioma, Prognosis, Staging, biotin, CD34 antigen, monoclonal antibody, peroxidase, streptavidin, adult, article, cancer staging, cancer survival, female, human, immunohistochemistry, immunoperoxidase staining, major clinical study, male, priority journal, statistical analysis, tumor growth, Age Factors, Antigens, CD34, Cohort Studies, Endothelium, Vascular, Hemoglobins, Humans, Immunoenzyme Techniques, Mesothelioma, Neoplasms, Mesothelial, Neovascularization, Pathologic, Platelet Count, Risk Factors, Survival Rate|
|Divisions:||Current > Schools > School of Biomedical Sciences
Current > QUT Faculties and Divisions > Faculty of Health
Current > Institutes > Institute of Health and Biomedical Innovation
|Copyright Owner:||Copyright 2001 Nature Publishing Group|
|Deposited On:||03 Dec 2013 06:37|
|Last Modified:||03 Dec 2013 06:37|
Repository Staff Only: item control page